IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Provectus Biopharmaceuticals,

Q4 2017 vs Q1 2018

Comparing institutional holders between quarters

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Vantage Investment Advisors, LLC
UNCHANGED
Shares1,318 from 1,318
Change0 (0%)
Value$0 ($0)
Filed 2018-05-10
Status
Vantage Investment Advisors, LLC
UNCHANGED1,3181,31800%$0$0$02018-05-10
Showing 1 of 1 institutions